Received Mar 18, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| TYP | TYPHOID LIVE ORAL TY21A (VIVOTIF) | BERNA BIOTECH, LTD. | 4 | Unknown | — |
The patient took four doses of Vivotif which weren't refrigerated; The patient took four doses of Vivotif which weren't refrigerated; The patient took four doses of Vivotif which weren't refrigerated; Case reference number US-BN-2025-000973 is a spontaneous case initially received from other health care professional via Communication (reference number: USBAV25-1272) on 30-May-2025 and concerns a 53-year-old, female patient. The patient's medical history and concomitant medication details were not provided. On unspecified dates, the patient took four doses of Vivotif which weren't refrigerated (batch number: unknown) at unknown dose, route or site of administration for unknown indication. (explicitly coded as 'product storage error', 'product administration error' and 'product temperature excursion issue'). At the time of initial report, it was unknown if patient experienced any of adverse events due to Vivotif. No further information was provided.; Reporter's Comments: A 53-year-old female patient took four doses of Vivotif for unknown indication which weren't refrigerated, which is considered as product storage error, product administration error and product temperature excursion issue. It was unknown if patient experienced any of adverse events due to Vivotif. Product storage error, product administration error and product temperature excursion issue are considered as listed per company convention. The patient's medical history and concomitant medication details were not provided. Product storage error, product administration error and product temperature excursion issue are not related to the suspect vaccine, but to a human factor. This case is considered as non-serious.; Sender's Comments: A 53-year-old female patient took four doses of Vivotif for unknown indication which weren't refrigerated, which is considered as product storage error, product administration error and product temperature excursion issue. It was unknown if patient experienced any of adverse events due to Vivotif. Product storage error, product administration error and product temperature excursion issue are considered as listed per company convention. The patient's medical history and concomitant medication details were not provided. Product storage error, product administration error and product temperature excursion issue are not related to the suspect vaccine, but to a human factor. This case is considered as non-serious.
Comments: NONE